LeClair Wealth Partners’s JPMorgan Healthcare Leaders ETF JDOC Stock Holding History

LeClair Wealth Partners’s Portfolio JDOC Stock Details JDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,096	Closed	-$228K	–	155
2026 Q1	$228K	Buy	+4,096	New	+$237K	0.08%	98

Other funds holding JDOC

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LeClair Wealth Partners's JDOC Position: Q2 2026 in Review

LeClair Wealth Partners sold out of JPMorgan Healthcare Leaders ETF (JDOC) in Q2 2026, closing a stake of 4,096 shares — an estimated $228K sold.

LeClair Wealth Partners first reported a position in JDOC in Q1 2026 and held it in 1 quarter. The position peaked at $228K in Q1 2026. 6 funds tracked by Wall St. Rank hold JDOC as of Q2 2026.

LeClair Wealth Partners reported no remaining JPMorgan Healthcare Leaders ETF position as of Q2 2026 after selling out during the quarter.
LeClair Wealth Partners sold 4,096 JPMorgan Healthcare Leaders ETF shares in Q2 2026, an estimated $228K.
LeClair Wealth Partners first reported a position in JPMorgan Healthcare Leaders ETF in Q1 2026 and held it in 1 quarter.
LeClair Wealth Partners's JPMorgan Healthcare Leaders ETF position peaked at $228K in Q1 2026.
6 funds tracked by Wall St. Rank held JPMorgan Healthcare Leaders ETF as of Q2 2026.

Based on LeClair Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.